Cytokeratin 19 Polyclonal Antibody

<strong>Cytokeratin 19 Polyclonal Antibody</strong>_x000D_ <strong>Catalog number:</strong> B2015268_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 10 ug_x000D_ <strong>Molecular Weight or Concentration:</strong> 40 kDa_x000D_ <strong>Supplied as:</strong> Solution_x000D_ <strong>Applications:</strong> a molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> -20°C_x000D_ <strong>Keywords:</strong> Cell and organelle markers, CK 19, CK19, Cytokeratin 19, Cytoskeleton Marker, K19, K1CS, keratin 19, KRT19_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Atta IS. Efficacy of expressions of Arg-1, Hep Par-1, and CK19 in the diagnosis of the primary hepatocellular carcinoma subtypes and exclusion of the metastases Histol Histopathol. 2021 Sep;36(9):981-993._x000D_ 2: Lan WJ, Lin YM, Men ZH, Yan L. Surface-decorated S. cerevisiae for flow cytometric array immunoassay Anal Bioanal Chem. 2017 Sep;409(22):5259-5267._x000D_ 3: Ren J, Zhou ZL, Xu S, Yang YJ. Prognostic Significance of Cytokeratin 19 and Squamous Cell Cancer Antigen in Histologically Negative Sentinel Lymph Nodes of Cervical Squamous Cell Carcinoma Int J Gynecol Cancer. 2016 Nov;26(9):1679-1685._x000D_ 4: Van Eyken P, Sciot R, Callea F, Van der Steen K, Moerman P, Desmet VJ. The development of the intrahepatic bile ducts in man: a keratin-immunohistochemical study Hepatology. 1988 Nov-Dec;8(6):1586-95._x000D_ 5: Kasper M. Heterogeneity in the immunolocalization of cytokeratin specific monoclonal antibodies in the rat eye: evaluation of unusual epithelial tissue entities Histochemistry. 1991;95(6):613-20._x000D_ 6: Denk H, Pabst D, Abuja PM, Reihs R, Tessaro B, Zatloukal K, Lackner C. Senescence markers in focal nodular hyperplasia of the liver: pathogenic considerations on the basis of immunohistochemical results Mod Pathol. 2022 Jan;35(1):87-95._x000D_ 7: Akasofu M, Kawahara E, Kurumaya H, Nakanishi I. Immunohistochemical detection of breast specific antigens and cytokeratins in metastatic breast carcinoma in the liver Acta Pathol Jpn. 1993 Dec;43(12):736-44._x000D_ 8: Bodey B, Kaiser HE, Goldfarb RH. Immunophenotypically varied cell subpopulations in primary and metastatic human melanomas. Monoclonal antibodies for diagnosis, detection of neoplastic progression and receptor directed immunotherapy Anticancer Res. 1996 Jan-Feb;16(1):517-31._x000D_ 9: Petersen G, Song D, Hügle-Dörr B, Oldenburg I, Bautz EK. Mapping of linear epitopes recognized by monoclonal antibodies with gene-fragment phage display libraries Mol Gen Genet. 1995 Dec 10;249(4):425-31._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/10945693">10: Matsusaka S, Nakasho K, Terada N, Sugihara A, Tsujimura T, Takanashi T, Uematsu K, Okamoto E, Toyosaka A. Inhibition by an angiogenesis inhibitor, TNP-470, of the growth of a human hepatoblastoma heterotransplanted into nude mice J Pediatr Surg. 2000 Aug;35(8):1198-204. </a>_x000D_ _x000D_ <strong>Products Related to Cytokeratin 19 Polyclonal Antibody can be found at</strong> <a href="https://moleculardepot.com/product-category/Proteins/"> Proteins</a>